For years, women with PCOS navigated a diagnosis that didn't quite add up. The name pointed to the ovaries. The symptoms pointed everywhere else. On May 12, 2026, a global consortium published a landmark paper in The Lancet formally renaming the condition polyendocrine metabolic ovarian syndrome — PMOS. If your care has never quite addressed what you were actually experiencing, the science now agrees with you.

Walk into any pharmacy or scroll through Instagram and you will find products promising to restore your desire, improve your arousal, or reignite your spark. The marketing is confident. The claims are almost never backed by rigorous science. Here is what the evidence actually says.